- Injective partners with OndoFinance, bringing USDY tokenized treasury instrument to its platform, enhancing institutional RWA offerings and capital efficiency.
- The integration expands Real World Asset offerings and capital efficiency within Injective’s dApps.
- Launch of AINJ, an Injective Staking Exchange-Traded Product, developed with 21Shares, providing INJ exposure and staking rewards.
Discover how Injective’s strategic partnership with OndoFinance and the launch of AINJ promise to transform institutional DeFi engagement and capital efficiency.
Injective Partners with OndoFinance
Injective has announced a groundbreaking integration with OndoFinance. This partnership, which went live today, introduces new opportunities for institutional investors and expands the Real World Asset (RWA) offerings within the ecosystem. The integration brings USDY, an innovative tokenized treasury instrument, to their platform, potentially revolutionizing how traditional financial assets interact with decentralized finance (DeFi) applications.
Integration With OndoFinance
A leading blockchain platform, has announced the official integration of OndoFinance, marking a significant expansion in its institutional Real World Asset (RWA) offerings. This integration, effective immediately, introduces USDY, an innovative tokenized treasury instrument, to the ecosystem. The integration brings several key developments. USDY is now available for use across applications built on Injective, a move expected to increase capital efficiency within the network. Additionally, tokenized treasury offerings will now be embedded into their decentralized applications (dApps), including decentralized exchanges and money market platforms. This partnership represents Injective’s latest effort in its ongoing mission to tokenize traditional finance on-chain. The platform has been at the forefront of tokenized asset adoption, notably through its RWA module, which currently supports on-chain offerings such as foreign exchange (FX) and commodities.
Launch of AINJ – Injective Staking Exchange-Traded Product
Injective has unveiled AINJ, a Staking Exchange-Traded Product (ETP) developed in collaboration with 21Shares. This innovative product allows users to gain exposure to INJ through major traditional finance exchange venues and brokerages while simultaneously capturing staking rewards. 21Shares, a leading issuer of crypto ETPs, brings its extensive experience and strong reputation to this partnership. With a track record of working alongside major crypto projects and introducing innovative financial products, 21Shares has been instrumental in facilitating greater institutional involvement in the digital asset space. Their recent collaboration with Cathie Wood’s Ark Invest on the Bitcoin ETF, which manages over $3 billion in assets, underscores their credibility in the field. This partnership ensures that AINJ is supported by a reliable and established entity in the cryptocurrency financial products sector.
Conclusion
The integration of OndoFinance and the introduction of USDY are anticipated to open up new use cases for both institutional investors and RWA markets within the ecosystem. This development aligns with the growing trend of bridging traditional finance with decentralized blockchain technologies.
